You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
奧園健康(03662.HK)擬7871.36萬元收購萬勇發展70%股份 探索大健康業務機會
格隆匯 12-17 17:54

格隆匯12月17日丨奧園健康(03662.HK)宣佈,於2021年12月17日,公司的間接全資附屬公司亞洲大健康產業研究院擬向賣方Add Hero Holdings Limited(中國奧園的直接全資附屬公司)收購萬勇發展有限公司70%已發行股本,現金代價為人民幣7871.36萬元。

據悉,於公吿日期,目標公司萬勇發展由賣方全資擁有,而其擁有萬利信的全部已發行股本。目標集團持有一個投資基金("投資基金")管理股份的33.33%權益及參與性無表決權股份的100%權益,投資基金乃根據開曼羣島法例成立,其惟一目的是直接投資於一間於開曼羣島註冊成立的獲豁免公司("目標實體")。投資基金的餘下權益由獨立第三方Innotech Capital Group Limited及廣東粵商聯合投資有限公司分別擁有約33.33%及約33.33%權益。目標實體為一間人工智能驅動的醫療保健公司,均根植於中國及美國,專注於通過DNA甲基化將早期癌症檢測測試商業化。於公吿日期,投資基金持有目標實體約5%的股權。

儘管集團專注於其提供物業管理服務及商業營運服務的核心業務,集團一直在評估大健康產業的表現及前景,且不時開拓其他商機,以制定整體業務策略,維持集團的增長及發展,為集團及股東爭取最大回報。董事會認為,收購事項為集團提供一個寶貴機會,與集團一直希望探索大健康業務的方向高度吻合,此符合集團的長期規劃以及戰略佈局。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account